Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0838 GMT – Regulatory clearance of Novo ...

The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...

Novo Holdings has completed regulatory conditions for its $16.5 billion acquisition of Catalent, aiming to increase production of Wegovy, a weight-loss drug. The deal includes selling three Catalent ...

Johnson & Johnson sues Cigna divisions, McKinsey resolves opioid charges, and numerous FDA approvals affect companies like ...